Statins--increasing or reducing the risk of Parkinson's disease?
Institut für Pharmakologie und Klinische Pharmazie, Philipps-Universität Marburg, Germany.
Amalia M
AM
Dolga
Carsten
C
Culmsee
Lonneke
L
de Lau
Yaroslav
Y
Winter
Wolfgang H
WH
Oertel
Paul G M
PG
Luiten
Ulrich L M
UL
Eisel
D000818:Animals; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000201:enzymology; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000201:enzymology; D012307:Risk Factors
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors